254 studies found for:    "Diphtheria"
Show Display Options
Rank Status Study
1 Completed Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older
Conditions: Diphtheria;   Tetanus;   Poliomyelitis;   Pertussis
Intervention: Biological: Diphtheria, tetanus, polio and pertussis vaccination
2 Completed Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis
Conditions: Pertussis;   Tetanus;   Diphtheria;   Poliomyelitis;   Hepatitis B
Interventions: Biological: Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV;   Biological: Hepatitis B vaccine
3 Completed
Has Results
Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
Conditions: Diphtheria;   Tetanus
Intervention: Biological: Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine
4 Completed Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Concomitant administration;   Biological: Separate administration
5 Completed
Has Results
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis
6 Completed
Has Results
Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B
Conditions: Diphtheria;   Pertussis;   Tetanus;   Hepatitis B;   Haemophilus Influenzae Infections
Intervention: Biological: Quinvaxem
7 Unknown  An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Td5ap;   Biological: Td1aP
8 Completed Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
Conditions: Pertussis;   Whooping Cough;   Tetanus;   Lockjaw;   Diphtheria
Interventions: Biological: Different antigen doses of Acellular Pertussis (aP) vaccine and Tetanus-Diphtheria (Td) booster vaccine;   Biological: Different antigen doses of Acellular Pertussis (aP), Tetanus (T) and Diphtheria (D) vaccine;   Biological: Licensed comparator Tdap booster vaccine
9 Completed Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio
Intervention: Drug: Boostrix polio
10 Active, not recruiting Study of SP306 Given Intramuscularly Compared to DT BIK® Given Subcutaneously in Japanese Adolescents 11 to 12 Years Old
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed;   Biological: Diphtheria and Tetanus toxoids adsorbed
11 Completed
Has Results
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine
Conditions: Meningitis;   Meningococcemia;   Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: T dap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Tdap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conj. + T dap
12 Completed
Has Results
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
Conditions: Meningococcal Meningitis;   Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis
Intervention: Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine
13 Completed Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
Conditions: Tetanus;   Diphtheria;   Pertussis;   Measles;   Polio
Interventions: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella Virus
14 Completed REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-Old Children
Conditions: Diphtheria;   Tetanus;   Poliomyelitis
Interventions: Biological: REVAXIS®;   Biological: DT-Polio®
15 Completed
Has Results
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
Conditions: Diphtheria;   Pertussis;   Diphtheria-Tetanus-acellular Pertussis Vaccines;   Tetanus
Interventions: Biological: Boostrix®;   Biological: Decavac™
16 Completed Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.
Conditions: Poliomyelitis;   Diphtheria;   Pertussis;   Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines;   Tetanus
Interventions: Biological: Boostrix Polio™ 711866;   Biological: Priorix Tetra TM 208136;   Biological: Tetravac TM
17 Terminated Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Conditions: Haemophilus Influenzae Type b;   Poliomyelitis;   Hepatitis B;   Serogroup C Meningococcal Diseases;   Diphtheria;   Pertussis;   Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccines;   Tetanus
Interventions: Biological: GSK2202083A vaccine;   Biological: Infanrix hexa;   Biological: Menjugate
18 Completed Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
Conditions: Diphtheria, Tetanus, Pertussis, Poliomyelitis & Haemophilus Influenzae Type b Disease;   Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines
Intervention: Biological: GSK Biologicals' combined DTPa-IPV/Hib vaccine
19 Completed
Has Results
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed;   Biological: DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed
20 Recruiting Post Marketing Surveillance for ADACEL™ in South Korea
Conditions: Diphtheria;   Tetanus;   Pertussis
Intervention: Biological: ADACEL™:Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years